Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Laser versus intradermal tranexamic acid for resistant melasma
IRCT20191011045057N1Phase 2Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of tranexamic acid in melasma (2 arms), sponsored by Isfahan University of Medical Sciences. Started Sep 2019; status: completed.
02
Drugs
tranexamic acid
03
Conditions
melasma
Beyond the preview
Go deeper on IRCT20191011045057N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20191011045057N1.